Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 514-523

  Santos, Isis S ^a   Ponte, Bruno M ^a   Boonme, Prapaporn ^b   Silva, Amélia M ^c,d   Souto, Eliana B ^a,c  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Colon cancer; Curcumin; Ellagic acid; Epigallocatechin 3 gallate; Gallic acid; Nanotechnology

Indexed keywords

CHEMOPREVENTIVE AGENTS; COLON CANCER; CURCUMIN; ENVIRONMENTAL FACTORS; EPIGALLOCATECHIN-3-GALLATE; GALLIC ACIDS; NANOPARTICULATE SYSTEM; SECONDARY METABOLITES;

BIOCHEMISTRY; ELLAGIC ACID; FREE RADICALS; NANOTECHNOLOGY; NUTRITION;

DISEASES;

ANTINEOPLASTIC AGENT; NANOCAPSULE; POLYPHENOL;

ANTIOXIDANT; BIOAVAILABILITY; CANCER; DIET; ELECTRON; NANOTECHNOLOGY; PHENOLIC COMPOUND; RADICAL; SECONDARY METABOLITE;

ANIMAL; CHEMISTRY; COLORECTAL TUMOR; HUMAN; REVIEW; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; HUMANS; NANOCAPSULES; POLYPHENOLS;

THEOBROMA CACAO;

EID: 84879411035     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.08.005     Document Type: Review

References (90)

1. Almeida A.J., Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007, 59:478-490.
2. Araujo J.R., Goncalves P., Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 2011, 31:77-87.
3. Arias J.L., Clares B., Morales M.E., Gallardo V., Ruiz M.A. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets 2011, 8:1151-1165.
4. Bartik L., Whitfield G.K., Kaczmarska M., Lowmiller C.L., Moffet E.W., Furmick J.K., et al. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 2010, 21:1153-1161.
5. Berger S.J., Gupta S., Belfi C.A., Gosky D.M., Mukhtar H. Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem Biophys Res Commun 2001, 288:101-105.
6. Boghossian S., Hawash A. Chemoprevention in colorectal cancer-where we stand and what we have learned from twenty year's experience. Surgeon 2012, 10:43-52.
7. Breunig M., Bauer S., Goepferich A. Polymers and nanoparticles: intelligent tools for intracellular targeting?. Eur J Pharm Biopharm 2008, 68:112-128.
8. Chang D., Wang F.A.N., Zhao Y.-S., Pan H.-Z. Evaluation of oxidative stress in colorectal cancer patients. Biomed Environ Sci 2008, 21:286-289.
9. Chen D., Dou Q.P. Tea polyphenols and their roles in cancer prevention and chemotherapy. Int J Mol Sci 2008, 9:1196-1206.
10. Collnot E.M., Ali H., Lehr C.M. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release 2012, 10.1016/j.jconrel.2012.01.028.
11. Cuffy M., Abir F., Longo W.E. Management of less common tumors of the colon, rectum, and anus. Clin Colorectal Cancer 2006, 5:327-337.
12. Das R.K., Kasoju N., Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010, 6:153-160.
13. Donsì F., Sessa M., Mediouni H., Mgaidi A., Ferrari G. Encapsulation of bioactive compounds in nanoemulsion-based delivery systems. Procedia Food Sci 2011, 1:1666-1671.
14. Draznin J., Sun W. Cancers of the bowel and hepatobiliary tract. Updat Cancer Ther 2006, 1:353-365.
15. Dube A., Nicolazzo J.A., Larson I. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Eur J Pharm Sci 2011, 44:422-426.
16. Ebrahimi A., Schluesener H. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev 2012, 11:329-345.
17. El Sebaï H., Ged C., Bonichon F., De Verneuil H., Longy M. Genetic alterations in colorectal cancer, comparative analysis of deletion events, and point mutations. Cancer Genet Cytogenet 1998, 104:32-38.
18. Ellis H. Anatomy of the caecum, appendix and colon. Surgery (Oxford) 2011, 29:1-4.
19. Espín J.C., García-Conesa M.T., Tomás-Barberán F.A. Nutraceuticals: facts and fiction. Phytochemistry 2007, 68:2986-3008.
20. Faller A.L.K., Fialho E. Polyphenol content and antioxidant capacity in organic and conventional plant foods. J Food Compos Anal 2010, 23:561-568.
21. Fang Z., Bhandari B. Encapsulation of polyphenols - a review. Trends Food Sci Technol 2010, 21:510-523.
22. Fang J., Seki T., Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009, 61:290-302.
23. Fangueiro J.F., Andreani T., Egea M.A., Garcia M.L., Souto S.B., Souto E.B. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process. Colloids Surf B Biointerfaces 2012, 10.1016/j.colsurfb.2012.04.014.
24. Fasolo D., Schwingel L., Holzschuh M., Bassani V., Teixeira H. Validation of an isocratic LC method for determination of quercetin and methylquercetin in topical nanoemulsions. J Pharm Biomed Anal 2007, 44:1174-1177.
25. Flis S., Jastrzebski Z., Namiesnik J., Arancibia-Avila P., Toledo F., Leontowicz H., et al. Evaluation of inhibition of cancer cell proliferation in vivo with different berries and correlation with their antioxidant levels by advanced analytical methods. J Pharm Biomed Anal 2012, 62:68-78.
26. Foss F.A., West K.P., McGregor A.H. Pathology of polyps detected in the bowel cancer screening programme. Diagn Histopathol 2011, 17:495-504.
27. Giftson Senapathy J., Jayanthi S., Viswanathan P., Umadevi P., Nalini N. Effect of gallic acid on xenobiotic metabolizing enzymes in 1,2-dimethyl hydrazine induced colon carcinogenesis in Wistar rats - a chemopreventive approach. Food Chem Toxicol 2011, 49:887-892.
28. Giftson J.S., Jayanthi S., Nalini N. Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 2010, 28:251-259.
29. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
30. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?. Arch Biochem Biophys 2008, 476:107-112.
31. Han X., Shen T., Lou H. Dietary polyphenols and their biological significance. Int J Mol Sci 2007, 8:950-988.
32. Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Lett 2008, 269:262-268.
33. Hervert-Hernández D., García O.P., Rosado J.L., Goñi I. The contribution of fruits and vegetables to dietary intake of polyphenols and antioxidant capacity in a Mexican rural diet: importance of fruit and vegetable variety. Food Res Int 2011, 44:1182-1189.
34. Hostanska K., Jürgenliemk G., Abel G., Nahrstedt A., Saller R. Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells. Cancer Detect Prev 2007, 31:129-139.
35. Hu B., Ting Y., Yang X., Tang W., Zeng X., Huang Q. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun (Camb) 2012, 48:2421-2423.
36. Irving G.R., Karmokar A., Berry D.P., Brown K., Steward W.P. Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 2011, 25:519-534.
37. Kelsey N.A., Wilkins H.M., Linseman D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010, 15:7792-7814.
38. Kim T.H., Jiang H.H., Youn Y.S., Park C.W., Tak K.K., Lee S., et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011, 403:285-291.
39. Kotsinas A., Aggarwal V., Tan E.J., Levy B., Gorgoulis V.G. PIG3: a novel link between oxidative stress and DNA damage response in cancer. Cancer Lett 2011, 10.1016/j.canlet.2011.12.009.
40. Kryston T.B., Georgiev A.B., Pissis P., Georgakilas A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res Fundam Mol Mech Mutagen 2011, 711:193-201.
41. Landete J.M. Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 2011, 44:1150-1160.
42. Larrosa M., Tomas-Barberan F.A., Espin J.C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 2006, 17:611-625.
43. Larrosa M., Garcia-Conesa M.T., Espin J.C., Tomas-Barberan F.A. Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 2010, 31:513-539.
44. Lemarchand C., Gref R., Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 2004, 58:327-341.
45. Liang J., Li F., Fang Y., Yang W., An X., Zhao L., et al. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles. Colloids Surf B Biointerfaces 2011, 82:297-301.
46. Liechty W.B., Peppas N.A. Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur J Pharm Biopharm 2012, 80:241-246.
47. Liew C.V., Chan L.W., Ching A.L., Heng P.W.S. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm 2006, 309:25-37.
48. Lim S.J., Lee M.K., Kim C.K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004, 100:53-61.
49. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005, 57:1595-1639.
50. Malik A., Afaq S., Shahid M., Akhtar K., Assiri A. Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway. Asian Pac J Trop Med 2011, 4:550-555.
51. Mazzarino L., Travelet C., Ortega-Murillo S., Otsuka I., Pignot-Paintrand I., Lemos-Senna E., et al. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. J Colloid Interface Sci 2012, 370:58-66.
52. Montoro P., Braca A., Pizza C., de Tommasi N. Structure-antioxidant activity relationships of flavonoids isolated from different plant species. Food Chem 2005, 92:349-355.
53. Mosca L., Marcellini S., Perluigi M., Mastroiacovo P., Moretti S., Famularo G., et al. Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula. Biochem Pharmacol 2002, 63:1305-1314.
54. Mudshinge S.R., Deore A.B., Patil S., Bhalgat C.M. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 2011, 19:129-141.
55. Nair H.B., Sung B., Yadav V.R., Kannappan R., Chaturvedi M.M., Aggarwal B.B. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010, 80:1833-1843.
56. Nayak A.P., Tiyaboonchai W., Patankar S., Madhusudhan B., Souto E.B. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces 2010, 81:263-273.
57. Neves M.J., Matos C.M., Moutinho C.G., Gomes L.R., Teixeira T. Actividade antioxidante e avaliação in vitro da citotoxicidade de extractos aquosos de Menthaxpiperita. Rev Fac Ciênc Saúde 2009, 6:344-354.
58. Obeidat W.M., Schwabe K., Müller R.H., Keck C.M. Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 2010, 76:56-67.
59. Ohishi T., Kishimoto Y., Miura N., Shiota G., Kohri T., Hara Y., et al. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett 2002, 177:49-56.
60. Park J.H., Lee S., Kim J.-H., Park K., Kim K., Kwon I.C. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 2008, 33:113-137.
61. Ponz De Leon M., Di Gregorio C. Pathology of colorectal cancer. Dig Liver Dis 2001, 33:372-388.
62. Ponz De Leon M., Percesepe A. Pathogenesis of colorectal cancer. Dig Liver Dis 2000, 32:807-821.
63. Qi L., Xu Z., Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007, 43:184-193.
64. Rao J.P., Geckeler K.E. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 2011, 36:887-913.
65. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010, 49:1603-1616.
66. Rosillo M.A., Sanchez-Hidalgo M., Cárdeno A., Alarcón De La Lastra C. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 2011, 82:737-745.
67. Sahu A., Bora U., Kasoju N., Goswami P. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 2008, 4:1752-1761.
68. Sanna V., Sechi M. Nanoparticle therapeutics for prostate cancer treatment. Maturitas 2012, 10.1016/j.maturitas.2012.01.016.
69. Sanna V., Pintus G., Roggio A.M., Punzoni S., Posadino A.M., Arca A., et al. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 2011, 54:1321-1332.
70. Sedelnikova O.A., Redon C.E., Dickey J.S., Nakamura A.J., Georgakilas A.G., Bonner W.M. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res Rev Mutat Res 2010, 704:152-159.
71. Sharma R.A., Manson M.M., Gescher A., Steward W.P. Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents. Eur J Cancer 2001, 37:12-22.
72. Sharma M., Li L., Celver J., Killian C., Kovoor A., Seeram N.P. Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J Agric Food Chem 2010, 58:3965-3969.
73. Siddiqui I.A., Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res 2010, 27:1054-1060.
74. Siddiqui I.A., Adhami V.M., Ahmad N., Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer 2010, 62:883-890.
75. Siddiqui I.A., Adhami V.M., Christopher J., Chamcheu, Mukhtar H. Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine 2012, 7:591-605.
76. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011, 82:1807-1821.
77. Singhal G.B., Patel R.P., Prajapati B.G., Patel N.A. Solid lipid nanoparticles and nano lipid carriers: as novel solid lipid based drug carrier. Int Res J Pharm 2011, 2:40-52.
78. Sousa C.M.M., Silva H.R., Vieira-Jr G.M., Ayres M.C.C., Cavalcante L.C.D., Barros E.D.S., et al. Fenóis totais e atividade antioxidante de cinco plantas medicinais. Quím Nova 2007, 30:351-355.
79. Thangapazham R.L., Sharma A., Maheshwari R.K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006, 8:E443-E449.
80. Thangapazham R.L., Singh A.K., Sharma A., Warren J., Gaddipati J.P., Maheshwari R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007, 245:232-241.
81. Umeda D., Yano S., Yamada K., Tachibana H. Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells. Biochem Biophys Res Commun 2008, 371:172-176.
82. Umesalma S., Sudhandiran G. Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol 2011, 660:249-258.
83. Vattem D.A., Shetty K. Ellagic acid production and phenolic antioxidant activity in cranberry pomace (Vaccinium macrocarpon) mediated by Lentinus edodes using a solid-state system. Process Biochem 2003, 39:367-379.
84. Verma B., Hucl P., Chibbar R.N. Phenolic acid composition and antioxidant capacity of acid and alkali hydrolysed wheat bran fractions. Food Chem 2009, 116:947-954.
85. Viennot S., Deleporte A., Moussata D., Nancey S., Flourié B., Reimund J.M. Colon cancer in inflammatory bowel disease: recent trends, questions and answers. Gastroenterol Clin Biol 2009, 33(Supplement 3):S190-S201.
86. Wang X., Jiang Y., Wang Y.-W., Huang M.-T., Ho C.-T., Huang Q. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem 2008, 108:419-424.
87. Wilson C.G. The transit of dosage forms through the colon. Int J Pharm 2010, 395:17-25.
88. Wojdyło A., Oszmiański J., Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem 2007, 105:940-949.
89. Wright T.I., Spencer J.M., Flowers F.P. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 2006, 54:933-946.
90. Yang G., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998, 19:611-616.